(1 - 17 from 23
)
Gradalis® Presents Initial Data from Phase II U.S. Trial
www.globenewswire.com
... John Nemunaitis, Chief Medical Officer of Gradalis. “In aggregate, these data presented at COG demonstrate Gradalis' approach of exploiting ...
Mary Crowley Medical Research Center - Dallas, Texas - Melanoma ...
melanomanewstoday.com
Principal Investigator: John Nemunaitis, MD. Please complete the information request form and you will be contacted once the investigational ...
Print - ZIOPHARM Reports Positive Interim Results in Patients With...
www.globenewswire.com
... and promising approach to the treatment of many cancers, including advanced melanoma," said Dr. John Nemunaitis, MD, Executive Medical ...
sorted by relevance / date